Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

August's Top Stories: Multiple recalls | Inpatient HF recommendations | CMS considers a big change

News You Need to Know Today
August's Top Stories: Multiple recalls | Inpatient HF recommendations | CMS considers a big change
Wednesday, September 4, 2024
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

The Month in Review

FDA announces recall of Inari Medical catheter after 6 deaths, 4 injuries

The FDA ruled that this is a Class I recall due to the significant risks for patients. Customers are not required to return the devices, however. Inari Medical has provided updated warnings and recommendations that should be followed. 

READ MORE >
The U.S. Food and Drug Administration (FDA) has announced that Inari Medical is recalling its ClotTriever XL catheter for removing blood clots and other blockages from large blood vessels. The news comes after the FDA received several reports of “serious adverse events” due to the device becoming entrapped or blocking arteries in the patient’s lungs. Six deaths and four other patient injuries have been associated with the issue so far.
Share on Twitter Share on Facebook Share on Linkedin

FDA announces recall of Inari Medical catheter after 6 deaths, 4 injuries

Share on Twitter Share on Facebook Share on Linkedin
The U.S. Food and Drug Administration (FDA) has announced that Inari Medical is recalling its ClotTriever XL catheter for removing blood clots and other blockages from large blood vessels. The news comes after the FDA received several reports of “serious adverse events” due to the device becoming entrapped or blocking arteries in the patient’s lungs. Six deaths and four other patient injuries have been associated with the issue so far.
The FDA ruled that this is a Class I recall due to the significant risks for patients. Customers are not required to return the devices, however. Inari Medical has provided updated warnings and recommendations that should be followed. 
READ MORE >

Cardiologist to chair new FDA advisory committee focused on AI, other digital health technologies

The Digital Health Advisory Committee is tasked with providing perspective and recommendations on a wide variety of topics. These insights will then help the FDA draft new policies and make other important decisions.

READ MORE >
Cardiologist Ami B. Bhatt, MD, a digital health specialist and longtime member of the American College of Cardiology (ACC), will serve as the Digital Health Advisory Committee's very first chair.
Share on Twitter Share on Facebook Share on Linkedin

Cardiologist to chair new FDA advisory committee focused on AI, other digital health technologies

Share on Twitter Share on Facebook Share on Linkedin
Cardiologist Ami B. Bhatt, MD, a digital health specialist and longtime member of the American College of Cardiology (ACC), will serve as the Digital Health Advisory Committee's very first chair.
The Digital Health Advisory Committee is tasked with providing perspective and recommendations on a wide variety of topics. These insights will then help the FDA draft new policies and make other important decisions.
READ MORE >

10 key updates from new American College of Cardiology inpatient heart failure recommendations

The new expert consensus decision pathway replaces a similar document from 2019 and is to be used in conjunction with heart failure guidelines published in 2022 by the ACC, American Heart Association and Heart Failure Society of America.

READ MORE >
Newsweek ranked the 50 best heart hospitals in the world
Share on Twitter Share on Facebook Share on Linkedin

10 key updates from new American College of Cardiology inpatient heart failure recommendations

Share on Twitter Share on Facebook Share on Linkedin
Newsweek ranked the 50 best heart hospitals in the world
The new expert consensus decision pathway replaces a similar document from 2019 and is to be used in conjunction with heart failure guidelines published in 2022 by the ACC, American Heart Association and Heart Failure Society of America.
READ MORE >

Cardiologists first in world to use new heart valve for TMVR, TTVR on same patient

Identical Cardiovalve systems were used to perform the procedures 18 months apart on a high-risk heart patient. 

READ MORE >
Cardiovalve heart valve transfemoral TMVR TTVR
Share on Twitter Share on Facebook Share on Linkedin

Cardiologists first in world to use new heart valve for TMVR, TTVR on same patient

Share on Twitter Share on Facebook Share on Linkedin
Cardiovalve heart valve transfemoral TMVR TTVR
Identical Cardiovalve systems were used to perform the procedures 18 months apart on a high-risk heart patient. 
READ MORE >

Johnson & Johnson to acquire heart failure specialists V-Wave for up to $1.7B

V-Wave has gained considerable attention for its Ventura Interatrial Shunt System, a small implantable device designed to reduce pressure on the left atrium and lungs of HFrEF patients.

READ MORE >
V-Wave has gained considerable attention or its Ventura Interatrial Shunt System, a small implantable device designed to reduce pressure on the left atrium and the lungs in patients with heart failure with reduced ejection fraction (HFrEF). The Ventura device includes a nitinol hourglass-shaped frame that anchors to the patient’s fossa ovalis in a way that prevents migration or embolization. It is implanted via an interventional procedure with fluoroscopy and echocardiography guidance.
Share on Twitter Share on Facebook Share on Linkedin

Johnson & Johnson to acquire heart failure specialists V-Wave for up to $1.7B

Share on Twitter Share on Facebook Share on Linkedin
V-Wave has gained considerable attention or its Ventura Interatrial Shunt System, a small implantable device designed to reduce pressure on the left atrium and the lungs in patients with heart failure with reduced ejection fraction (HFrEF). The Ventura device includes a nitinol hourglass-shaped frame that anchors to the patient’s fossa ovalis in a way that prevents migration or embolization. It is implanted via an interventional procedure with fluoroscopy and echocardiography guidance.
V-Wave has gained considerable attention for its Ventura Interatrial Shunt System, a small implantable device designed to reduce pressure on the left atrium and lungs of HFrEF patients.
READ MORE >

CMS may double Medicare payments for cardiac CT

The agency is gathering feedback on a proposal to double the amount hospitals are paid for coronary computed tomography angiography, with the comment period ending Sept. 9.

READ MORE >
Cardiac CT scan for a pre-procedural assessment of a left atrial appendage occlusion (LAAO) procedure at Duly Healthcare in the Chicago suburbs. Cardiac CT use has increased the past few years and now CMS is looking to double what it pays for them in the 2025 HOPPS proposed rule. Photo by Dave Fornell
Share on Twitter Share on Facebook Share on Linkedin

CMS may double Medicare payments for cardiac CT

Share on Twitter Share on Facebook Share on Linkedin
Cardiac CT scan for a pre-procedural assessment of a left atrial appendage occlusion (LAAO) procedure at Duly Healthcare in the Chicago suburbs. Cardiac CT use has increased the past few years and now CMS is looking to double what it pays for them in the 2025 HOPPS proposed rule. Photo by Dave Fornell
The agency is gathering feedback on a proposal to double the amount hospitals are paid for coronary computed tomography angiography, with the comment period ending Sept. 9.
READ MORE >

What cardiologists should expect as U.S. healthcare payment models evolve

Cardiologist Dan Blumenthal, MD, MBA, explains how changes in Medicare payments will greatly impact cardiology in the years ahead. In just a few short years, the business side of cardiology could look substantially different than it does today. 

READ MORE >
Dan Blumenthal, MD, MBA, chief quality officer at the Cardiovascular Associates of America, and a cardiologist at Massachusetts General Hospital, spoke at the Heart Rhythm Society (HRS) 2024 meeting business sessions on how changes in Medicare payments will impact electrophysiology and cardiology more broadly.
Share on Twitter Share on Facebook Share on Linkedin

What cardiologists should expect as U.S. healthcare payment models evolve

Share on Twitter Share on Facebook Share on Linkedin
Dan Blumenthal, MD, MBA, chief quality officer at the Cardiovascular Associates of America, and a cardiologist at Massachusetts General Hospital, spoke at the Heart Rhythm Society (HRS) 2024 meeting business sessions on how changes in Medicare payments will impact electrophysiology and cardiology more broadly.
Cardiologist Dan Blumenthal, MD, MBA, explains how changes in Medicare payments will greatly impact cardiology in the years ahead. In just a few short years, the business side of cardiology could look substantially different than it does today. 
READ MORE >

FDA clears chest-worn patch for simultaneous ECG, sleep apnea monitoring

The new device from Huxley Medical offers care teams a way to monitor patients for signs of sleep apnea while also keeping a close eye on their heart health. 

READ MORE >
Huxley Medical, an Atlanta-based medical device company, has secured U.S. Food and Drug Administration (FDA) clearance for its new Sansa device, a chest-worn patch designed to help diagnose sleep apnea in addition to tracking patient data with electrocardiograms (ECGs) and a variety of sensors.
Share on Twitter Share on Facebook Share on Linkedin

FDA clears chest-worn patch for simultaneous ECG, sleep apnea monitoring

Share on Twitter Share on Facebook Share on Linkedin
Huxley Medical, an Atlanta-based medical device company, has secured U.S. Food and Drug Administration (FDA) clearance for its new Sansa device, a chest-worn patch designed to help diagnose sleep apnea in addition to tracking patient data with electrocardiograms (ECGs) and a variety of sensors.
The new device from Huxley Medical offers care teams a way to monitor patients for signs of sleep apnea while also keeping a close eye on their heart health. 
READ MORE >

First-generation Medtronic TAVR valves linked to strong outcomes after 12 years

Researchers tracked the long-term safety, effectiveness and durability of first-generation CoreValve devices in nearly 900 patients.

READ MORE >
Medtronic CoreValve TAVR first-generation transcatheter heart valve
Share on Twitter Share on Facebook Share on Linkedin

First-generation Medtronic TAVR valves linked to strong outcomes after 12 years

Share on Twitter Share on Facebook Share on Linkedin
Medtronic CoreValve TAVR first-generation transcatheter heart valve
Researchers tracked the long-term safety, effectiveness and durability of first-generation CoreValve devices in nearly 900 patients.
READ MORE >

Automated chest compression device recalled after patient death

Regulators emphasized that these devices should not be used due to significant safety risks. 

READ MORE >
The U.S. Food and Drug Administration (FDA) has announced that Defibtech, a Nihon Kohden company, is recalling its RMU-2000 ARM XR Chest Compression Device due to significant safety concerns. This is a Class I recall, which means the FDA believes using the device “may cause serious injury or death.”
Share on Twitter Share on Facebook Share on Linkedin

Automated chest compression device recalled after patient death

Share on Twitter Share on Facebook Share on Linkedin
The U.S. Food and Drug Administration (FDA) has announced that Defibtech, a Nihon Kohden company, is recalling its RMU-2000 ARM XR Chest Compression Device due to significant safety concerns. This is a Class I recall, which means the FDA believes using the device “may cause serious injury or death.”
Regulators emphasized that these devices should not be used due to significant safety risks. 
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

Fraud allegations lead to $4.75M settlement | Hospital sues cardiology practice | A new business model | Whoop raises $575M
FDA clears AI for cardiac amyloidosis | SVS works to improve vascular care | Paravalvular leak after TTVR
Week in Review: Cardiologist says he was fired for speaking out | Millions of devices recalled | Hospital sues practice
A new approval for smallest defibrillation lead of its kind | Post-TAVR bleeding | Key details about reprocessed catheter recall
Medline recalls millions of devices due to safety risk | FDA's warning about sizing catheters | Post-TAVR bleeding events
Fighting for new cath lab safety standards | FDA confirms Impella recall | ‘Practice-changing’ research | Heart failure & PCI
New gene therapy targets a challenging condition | Big news out of Mount Sinai | First patients treated in PFA trial

Pagination

    • First page « First
    • Previous page ‹‹
    • Page …11
    • Page 12
    • Page 13
    • Page 14
    • Current page 15
    • Page 16
    • Page 17
    • Page 18
    • Page 19 …
    • Next page ››
    • Last page Last »
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
 
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
 
Design by Adaptive Theme
Trimed Popup